2 hours ago
2
MarketBeat
Sat, March 7, 2026 astatine 10:15 AM CST 8 min read
-
$89 million gross successful 2025 with 36% YoY maturation and 88% gross margins, positive $159 million currency and 31 consecutive quarters of sequential maturation — yet lone ~3% penetration (647 of ~6,000 U.S. hospitals), signaling important upside.
-
CeriBell expanded its level with pediatric/neonatal algorithm clearance and an babe caput headdress (launch planned successful Q2), received FDA clearance for delirium successful Nov 2025 and raised its TAM to astir $3.5 billion, and secured an FDA breakthrough designation for changeable successful Jan 2026.
-
The commercialized exemplary combines ~25% subscription gross (≈97% gross margin) and ~75% disposable headbands, portion go-to-market investments expanded territory sum from ~35 to 55 and achieved FedRAMP clearance to alteration VA sales.
-
Interested successful CeriBell, Inc.? Here are 5 stocks we similar better.
CeriBell (NASDAQ:CBLL) is seeking to accelerate adoption of its point-of-care EEG level successful U.S. hospitals portion expanding into caller diligent populations and indications, Chief Financial Officer Scott Blumberg said astatine the 47th Annual Raymond James Institutional Investors Conference.
Blumberg told investors the institution ended 2025 with $89 cardinal successful revenue, representing 36% year-over-year growth, and delivered 88% gross margins for the year. CeriBell’s commercialized absorption has been seizure detection successful acute attraction settings specified arsenic the ICU and exigency department, which Blumberg described arsenic an astir $2 cardinal full addressable market. He added that the institution reached aggregate milestones during 2025 aimed astatine expanding its opportunity, including algorithm enlargement to neonatal and pediatric patients and a archetypal clearance related to delirium detection, which helium said accrued CeriBell’s full addressable marketplace to astir $3.5 billion.
→ Uber and Joby Aviation Team Up: Game Changer oregon Hype?
Blumberg positioned CeriBell’s exertion arsenic addressing a captious situation successful diagnosing non-convulsive seizures successful acute care. In opposition to epilepsy-related seizures that are often visible, seizures successful ICU and ED settings are often non-convulsive, tin persist for hours oregon days, and tin beryllium life-threatening. He said 92% of seizures successful these patients are non-convulsive, making EEG the lone mode to diagnose them.
He emphasized the value of time-to-diagnosis successful cases of prolonged seizure activity, including “status epilepticus,” which helium described arsenic a society-defined word for a seizure lasting 5 minutes oregon more. Delays tin worsen outcomes, and helium noted that first-line attraction effectiveness declines arsenic clip passes, citing a one-hour hold arsenic materially reducing effectiveness.
English (CA) · 
English (US) · 
Spanish (MX) ·